- Home
- MRNA vs TW Comparison
MRNA vs TW Comparison
Compare MRNA & TW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MRNA | TW |
|---|---|---|
| Founded | 2010 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Investment Bankers/Brokers/Service |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 19.7B | 22.9B |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | MRNA | TW |
|---|---|---|
| Price | $49.11 | $123.30 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $33.00 | ★ $140.00 |
| AVG Volume (30 Days) | ★ 7.1M | 1.2M |
| Earning Date | 04-30-2026 | 04-29-2026 |
| Dividend Yield | N/A | ★ 0.47% |
| EPS Growth | 21.77 | ★ 62.23 |
| EPS | N/A | ★ 3.78 |
| Revenue | ★ $19,263,000,000.00 | $892,659,000.00 |
| Revenue This Year | $8.59 | $16.56 |
| Revenue Next Year | $16.72 | $10.67 |
| P/E Ratio | ★ N/A | $31.31 |
| Revenue Growth | 4.29 | ★ 15.10 |
| 52 Week Low | $22.28 | $97.06 |
| 52 Week High | $59.55 | $148.58 |
Technical Indicators
Market Signals| Indicator | MRNA | TW |
|---|---|---|
| Relative Strength Index (RSI) | 45.17 | 54.90 |
| Support Level | $48.09 | $121.69 |
| Resistance Level | $54.94 | $126.77 |
| Average True Range (ATR) | 2.63 | 3.07 |
| MACD | -0.77 | -0.86 |
| Stochastic Oscillator | 17.40 | 59.26 |
Price Performance
Historical ComparisonAbout MRNA Moderna Inc.
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
About TW Tradeweb Markets Inc.
Founded in 1998 and headquartered in New York City, Tradeweb Markets is a leading fixed-income trading platform. While it does offer electronic processing for some voice-negotiated trades, the company focuses primarily on providing electronic trading networks that connect broker/dealers, institutional clients, and retail customers. While the company offers trading in a wide variety of products, the bulk of its business is in US and European government debt, mortgage-backed securities, interest-rate swaps, and US and international corporate bonds. The firm also sells fixed-income trading and price data, primarily through a deal with Refinitiv's Eikon service.